Fibrotic diseases of the heart and liver impact a significant portion of the global population and are a growing public health concern. Understanding the underlying biology of fibrosis is critical for the diagnosis, treatment, and management of cardiac fibrosis, nonalcoholic steatohepatitis (NASH), and other fibrotic diseases.
